IPR Details
IBM's Patent Claim on PTOPOMIB

The text of the original IPR disclosure is available in the disclosure history.

Submitted: April 29, 1998

Note: Updates to IPR disclosures must only be made by authorized representatives of the original submitters. Updates will automatically be forwarded to the current Patent Holder's Contact and to the Submitter of the original IPR disclosure.

I. Patent Holder/Applicant ("Patent Holder")

Holder legal name
IBM Corporation

II. Patent Holder's Contact for License Application

Holder contact name
John Tavs
Holder contact email
tavs@raleigh.ibm.com
Holder contact info

IBM Director of Licensing
North Castle Drive, Armonk, N.Y., 10504

III. IETF Document or Other Contribution to Which this IPR Disclosure Relates

Designations for Other Contributions
PTOPOMIB

IV. Disclosure of Patent Information i.e., patents or patent applications required to be disclosed by Section 6 of RFC 8179

A. For granted patents or published pending patent applications, please provide the following information:

Patent, Serial, Publication, Registration, or Application/File number(s)

5276440

B. Does this disclosure relate to an unpublished pending patent application?:

Has patent pending
No

V. Licensing Declaration

The Patent Holder states that its position with respect to licensing any patent claims contained in the patent(s) or patent application(s) disclosed above that would necessarily be infringed by implementation of the technology required by the relevant IETF specification ("Necessary Patent Claims"), for the purpose of implementing such specification, is as follows(select one licensing declaration option only):

Licensing
See Text Below for Licensing Declaration
Licensing information, comments, notes, or URL for further information

This is to advise the IETF that IBM believes it has a patent (5276440)
that relates to ptopomib, and in accordance with the intellectual
property rights procedures of the IETF standards process,

IBM is willing to offer, upon written request from the implementers of
the ptopomib, a non-exclusive license under reasonable and
non-discriminatory terms and conditions.

Note: The individual submitting this template represents and warrants that he or she is authorized by the Patent Holder to agree to the above-selected licensing declaration.

VI. Contact Information of Submitter of this Form

Submitter name
John Tavs
Submitter email
tavs@raleigh.ibm.com

Only those sections of the relevant entry form where the submitter provided information are displayed.